Epistasis
Epistasis
Main page
329472

Epistasis

logo
Community Hub0 subscribers
Read side by side
Epistasis
View on Wikipedia
from Wikipedia
An example of epistasis is the interaction between hair colour and baldness. A gene for total baldness would be epistatic to one for blond hair or red hair. The hair-colour genes are hypostatic to the baldness gene. The baldness phenotype supersedes genes for hair colour, and so the effects are non-additive.[citation needed]
Example of epistasis in coat colour genetics: If no pigments can be produced the other coat colour genes have no effect on the phenotype, no matter if they are dominant or if the individual is homozygous. Here the genotype "c c" for no pigmentation is epistatic over the other genes.[1]

Epistasis is a phenomenon in genetics in which the effect of a gene mutation is dependent on the presence or absence of mutations in one or more other genes, respectively termed modifier genes. In other words, the effect of the mutation is dependent on the genetic background in which it appears.[2] Epistatic mutations therefore have different effects on their own than when they occur together. Originally, the term epistasis specifically meant that the effect of a gene variant is masked by that of a different gene.[3]

The concept of epistasis originated in genetics in 1907[4] but is now used in biochemistry, computational biology and evolutionary biology. The phenomenon arises due to interactions, either between genes (such as mutations also being needed in regulators of gene expression) or within them (multiple mutations being needed before the gene loses function), leading to non-linear effects. Epistasis has a great influence on the shape of evolutionary landscapes, which leads to profound consequences for evolution and for the evolvability of phenotypic traits.

History

[edit]

Understanding of epistasis has changed considerably through the history of genetics and so too has the use of the term. The term was first used in 1907 by William Bateson and his collaborators Florence Durham and Muriel Wheldale Onslow.[5][4] In early models of natural selection devised in the early 20th century, each gene was considered to make its own characteristic contribution to fitness, against an average background of other genes. Some introductory courses still teach population genetics this way. Because of the way that the science of population genetics was developed, evolutionary geneticists have tended to think of epistasis as the exception. However, in general, the expression of any one allele depends in a complicated way on many other alleles.

In classical genetics, if genes A and B are mutated, and each mutation by itself produces a unique phenotype but the two mutations together show the same phenotype as the gene A mutation, then gene A is epistatic and gene B is hypostatic. For example, the gene for total baldness is epistatic to the gene for brown hair. In this sense, epistasis can be contrasted with genetic dominance, which is an interaction between alleles at the same gene locus. As the study of genetics developed, and with the advent of molecular biology, epistasis started to be studied in relation to quantitative trait loci (QTL) and polygenic inheritance.

The effects of genes are now commonly quantifiable by assaying the magnitude of a phenotype (e.g. height, pigmentation or growth rate) or by biochemically assaying protein activity (e.g. binding or catalysis). Increasingly sophisticated computational and evolutionary biology models aim to describe the effects of epistasis on a genome-wide scale and the consequences of this for evolution.[6][7][8] Since identification of epistatic pairs is challenging both computationally and statistically, some studies try to prioritize epistatic pairs.[9][10]

Classification

[edit]
Quantitative trait values after two mutations either alone (Ab and aB) or in combination (AB). Bars contained in the grey box indicate the combined trait value under different circumstances of epistasis. Upper panel indicates epistasis between beneficial mutations (blue).[11][12] Lower panel indicates epistasis between deleterious mutations (red).[13][14]
Since, on average, mutations are deleterious, random mutations to an organism cause a decline in fitness. If all mutations are additive, fitness will fall proportionally to mutation number (black line). When deleterious mutations display negative (synergistic) epistasis, they are more deleterious in combination than individually and so fitness falls with the number of mutations at an increasing rate (upper, red line). When mutations display positive (antagonistic) epistasis, effects of mutations are less severe in combination than individually and so fitness falls at a decreasing rate (lower, blue line).[13][14][15][16]

Terminology about epistasis can vary between scientific fields. Geneticists often refer to wild type and mutant alleles where the mutation is implicitly deleterious and may talk in terms of genetic enhancement, synthetic lethality and genetic suppressors. Conversely, a biochemist may more frequently focus on beneficial mutations and so explicitly state the effect of a mutation and use terms such as reciprocal sign epistasis and compensatory mutation.[17] Additionally, there are differences when looking at epistasis within a single gene (biochemistry) and epistasis within a haploid or diploid genome (genetics). In general, epistasis is used to denote the departure from 'independence' of the effects of different genetic loci. Confusion often arises due to the varied interpretation of 'independence' among different branches of biology.[18] The classifications below attempt to cover the various terms and how they relate to one another.

Additivity

[edit]

Two mutations are considered to be purely additive if the effect of the double mutation is the sum of the effects of the single mutations. This occurs when genes do not interact with each other, for example by acting through different metabolic pathways. Simply, additive traits were studied early on in the history of genetics, however they are relatively rare, with most genes exhibiting at least some level of epistatic interaction.[19][20]

Magnitude epistasis

[edit]

When the double mutation has a fitter phenotype than expected from the effects of the two single mutations, it is referred to as positive epistasis. Positive epistasis between beneficial mutations generates greater improvements in function than expected.[11][12] Positive epistasis between deleterious mutations protects against the negative effects to cause a less severe fitness drop.[14]

Conversely, when two mutations together lead to a less fit phenotype than expected from their effects when alone, it is called negative epistasis.[21][22] Negative epistasis between beneficial mutations causes smaller than expected fitness improvements, whereas negative epistasis between deleterious mutations causes greater-than-additive fitness drops.[13]

Independently, when the effect on fitness of two mutations is more radical than expected from their effects when alone, it is referred to as synergistic epistasis. The opposite situation, when the fitness difference of the double mutant from the wild type is smaller than expected from the effects of the two single mutations, it is called antagonistic epistasis.[16] Therefore, for deleterious mutations, negative epistasis is also synergistic, while positive epistasis is antagonistic; conversely, for advantageous mutations, positive epistasis is synergistic, while negative epistasis is antagonistic.

The term genetic enhancement is sometimes used when a double (deleterious) mutant has a more severe phenotype than the additive effects of the single mutants. Strong positive epistasis is sometimes referred to by creationists as irreducible complexity (although most examples are misidentified).

Sign epistasis

[edit]

Sign epistasis[23] occurs when one mutation has the opposite effect when in the presence of another mutation. This occurs when a mutation that is deleterious on its own can enhance the effect of a particular beneficial mutation.[18] For example, a large and complex brain is a waste of energy without a range of sense organs, but sense organs are made more useful by a large and complex brain that can better process the information. If a fitness landscape has no sign epistasis then it is called smooth.

At its most extreme, reciprocal sign epistasis[24] occurs when two deleterious genes are beneficial when together. For example, producing a toxin alone can kill a bacterium, and producing a toxin exporter alone can waste energy, but producing both can improve fitness by killing competing organisms. If a fitness landscape has sign epistasis but no reciprocal sign epistasis then it is called semismooth.[25]

Reciprocal sign epistasis also leads to genetic suppression whereby two deleterious mutations are less harmful together than either one on its own, i.e. one compensates for the other. A clear example of genetic suppression was the demonstration that in the assembly of bacteriophage T4 two deleterious mutations, each causing a deficiency in the level of a different morphogenetic protein, could interact positively.[26] If a mutation causes a reduction in a particular structural component, this can bring about an imbalance in morphogenesis and loss of viable virus progeny, but production of viable progeny can be restored by a second (suppressor) mutation in another morphogenetic component that restores the balance of protein components.

The term genetic suppression can also apply to sign epistasis where the double mutant has a phenotype intermediate between those of the single mutants, in which case the more severe single mutant phenotype is suppressed by the other mutation or genetic condition. For example, in a diploid organism, a hypomorphic (or partial loss-of-function) mutant phenotype can be suppressed by knocking out one copy of a gene that acts oppositely in the same pathway. In this case, the second gene is described as a "dominant suppressor" of the hypomorphic mutant; "dominant" because the effect is seen when one wild-type copy of the suppressor gene is present (i.e. even in a heterozygote). For most genes, the phenotype of the heterozygous suppressor mutation by itself would be wild type (because most genes are not haplo-insufficient), so that the double mutant (suppressed) phenotype is intermediate between those of the single mutants.

In non reciprocal sign epistasis, fitness of the mutant lies in the middle of that of the extreme effects seen in reciprocal sign epistasis.

When two mutations are viable alone but lethal in combination, it is called Synthetic lethality or unlinked non-complementation.[27]

Haploid organisms

[edit]

In a haploid organism with genotypes (at two loci) ab, Ab, aB or AB, we can think of different forms of epistasis as affecting the magnitude of a phenotype upon mutation individually (Ab and aB) or in combination (AB).

Interaction type ab Ab aB AB
No epistasis (additive)  0 1 1 2 AB = Ab + aB + ab 
Positive (synergistic) epistasis 0 1 1 3 AB > Ab + aB + ab 
Negative (antagonistic) epistasis 0 1 1 1 AB < Ab + aB + ab 
Sign epistasis 0 1 -1 2 AB has opposite sign to Ab or aB
Reciprocal sign epistasis 0 -1 -1 2 AB has opposite sign to Ab and aB

Diploid organisms

[edit]

Epistasis in diploid organisms is further complicated by the presence of two copies of each gene. Epistasis can occur between loci, but additionally, interactions can occur between the two copies of each locus in heterozygotes. For a two locus, two allele system, there are eight independent types of gene interaction.[28]

Additive A locus Additive B locus Dominance A locus Dominance B locus
aa aA AA aa aA AA aa aA AA aa aA AA
bb 1 0 –1 bb 1 1 1 bb –1 1 –1 bb –1 –1 –1
bB 1 0 –1 bB 0 0 0 bB –1 1 –1 bB 1 1 1
BB 1 0 –1 BB –1 –1 –1 BB –1 1 –1 BB –1 –1 –1
Additive by Additive Epistasis Additive by Dominance Epistasis Dominance by Additive Epistasis Dominance by Dominance Epistasis
aa aA AA aa aA AA aa aA AA aa aA AA
bb 1 0 –1 bb 1 0 –1 bb 1 –1 1 bb –1 1 –1
bB 0 0 0 bB –1 0 1 bB 0 0 0 bB 1 –1 1
BB –1 0 1 BB 1 0 –1 BB –1 1 –1 BB –1 1 –1

Genetic and molecular causes

[edit]

Additivity

[edit]

This can be the case when multiple genes act in parallel to achieve the same effect. For example, when an organism is in need of phosphorus, multiple enzymes that break down different phosphorylated components from the environment may act additively to increase the amount of phosphorus available to the organism. However, there inevitably comes a point where phosphorus is no longer the limiting factor for growth and reproduction and so further improvements in phosphorus metabolism have smaller or no effect (negative epistasis). Some sets of mutations within genes have also been specifically found to be additive.[29] It is now considered that strict additivity is the exception, rather than the rule, since most genes interact with hundreds or thousands of other genes.[19][20]

Epistasis between genes

[edit]

Epistasis within the genomes of organisms occurs due to interactions between the genes within the genome. This interaction may be direct if the genes encode proteins that, for example, are separate components of a multi-component protein (such as the ribosome), inhibit each other's activity, or if the protein encoded by one gene modifies the other (such as by phosphorylation). Alternatively the interaction may be indirect, where the genes encode components of a metabolic pathway or network, developmental pathway, signalling pathway or transcription factor network. For example, the gene encoding the enzyme that synthesizes penicillin is of no use to a fungus without the enzymes that synthesize the necessary precursors in the metabolic pathway.

Epistasis within genes

[edit]

Just as mutations in two separate genes can be non-additive if those genes interact, mutations in two codons within a gene can be non-additive. In genetics this is sometimes called intragenic suppression when one deleterious mutation can be compensated for by a second mutation within that gene. Analysis of bacteriophage T4 mutants that were altered in the rIIB cistron (gene) revealed that certain pairwise combinations of mutations could mutually suppress each other; that is the double mutants had a more nearly wild-type phenotype than either mutant alone.[30] The linear map order of the mutants was established using genetic recombination data, From these sources of information, the triplet nature of the genetic code was logically deduced for the first time in 1961, and other key features of the code were also inferred.[30]

Also intragenic suppression can occur when the amino acids within a protein interact. Due to the complexity of protein folding and activity, additive mutations are rare.

Proteins are held in their tertiary structure by a distributed, internal network of cooperative interactions (hydrophobic, polar and covalent).[31] Epistatic interactions occur whenever one mutation alters the local environment of another residue (either by directly contacting it, or by inducing changes in the protein structure).[32] For example, in a disulphide bridge, a single cysteine has no effect on protein stability until a second is present at the correct location at which point the two cysteines form a chemical bond which enhances the stability of the protein.[33] This would be observed as positive epistasis where the double-cysteine variant had a much higher stability than either of the single-cysteine variants. Conversely, when deleterious mutations are introduced, proteins often exhibit mutational robustness whereby as stabilising interactions are destroyed the protein still functions until it reaches some stability threshold at which point further destabilising mutations have large, detrimental effects as the protein can no longer fold. This leads to negative epistasis whereby mutations that have little effect alone have a large, deleterious effect together.[34][35]

In enzymes, the protein structure orients a few, key amino acids into precise geometries to form an active site to perform chemistry.[36] Since these active site networks frequently require the cooperation of multiple components, mutating any one of these components massively compromises activity, and so mutating a second component has a relatively minor effect on the already inactivated enzyme. For example, removing any member of the catalytic triad of many enzymes will reduce activity to levels low enough that the organism is no longer viable.[37][38][39]

Heterozygotic epistasis

[edit]

Diploid organisms contain two copies of each gene. If these are different (heterozygous / heteroallelic), the two different copies of the allele may interact with each other to cause epistasis. This is sometimes called allelic complementation, or interallelic complementation. It may be caused by several mechanisms, for example transvection, where an enhancer from one allele acts in trans to activate transcription from the promoter of the second allele. Alternately, trans-splicing of two non-functional RNA molecules may produce a single, functional RNA.

Similarly, at the protein level, proteins that function as dimers may form a heterodimer composed of one protein from each alternate gene and may display different properties to the homodimer of one or both variants. Two bacteriophage T4 mutants defective at different locations in the same gene can undergo allelic complementation during a mixed infection.[40] That is, each mutant alone upon infection cannot produce viable progeny, but upon mixed infection with two complementing mutants, viable phage are formed. Intragenic complementation was demonstrated for several genes that encode structural proteins of the bacteriophage[40] indicating that such proteins function as dimers or even higher order multimers.[41]

Evolutionary consequences

[edit]

Fitness landscapes and evolvability

[edit]
The top row indicates interactions between two genes that show either (a) additive effects, (b) positive epistasis or (c) reciprocal sign epistasis. Below are fitness landscapes which display greater and greater levels of global epistasis between large numbers of genes. Purely additive interactions lead to a single smooth peak (d); as increasing numbers of genes exhibit epistasis, the landscape becomes more rugged (e), and when all genes interact epistatically the landscape becomes so rugged that mutations have seemingly random effects (f).
See also: fitness landscape and evolvability

In evolutionary genetics, the sign of epistasis is usually more significant than the magnitude of epistasis. This is because magnitude epistasis (positive and negative) simply affects how beneficial mutations are together, however sign epistasis affects whether mutation combinations are beneficial or deleterious.[11]

A fitness landscape is a representation of the fitness where all genotypes are arranged in 2D space and the fitness of each genotype is represented by height on a surface. It is frequently used as a visual metaphor for understanding evolution as the process of moving uphill from one genotype to the next, nearby, fitter genotype.[19]

If all mutations are additive, they can be acquired in any order and still give a continuous uphill trajectory. The landscape is perfectly smooth, with only one peak (global maximum) and all sequences can evolve uphill to it by the accumulation of beneficial mutations in any order. Conversely, if mutations interact with one another by epistasis, the fitness landscape becomes rugged as the effect of a mutation depends on the genetic background of other mutations.[42] At its most extreme, interactions are so complex that the fitness is 'uncorrelated' with gene sequence and the topology of the landscape is random. This is referred to as a rugged fitness landscape and has profound implications for the evolutionary optimisation of organisms. If mutations are deleterious in one combination but beneficial in another, the fittest genotypes can only be accessed by accumulating mutations in one specific order. This makes it more likely that organisms will get stuck at local maxima in the fitness landscape having acquired mutations in the 'wrong' order.[35][43] For example, a variant of TEM1 β-lactamase with 5 mutations is able to cleave cefotaxime (a third generation antibiotic).[44] However, of the 120 possible pathways to this 5-mutant variant, only 7% are accessible to evolution as the remainder passed through fitness valleys where the combination of mutations reduces activity. In contrast, changes in environment (and therefore the shape of the fitness landscape) have been shown to provide escape from local maxima.[35] In this example, selection in changing antibiotic environments resulted in a "gateway mutation" which epistatically interacted in a positive manner with other mutations along an evolutionary pathway, effectively crossing a fitness valley. This gateway mutation alleviated the negative epistatic interactions of other individually beneficial mutations, allowing them to better function in concert. Complex environments or selections may therefore bypass local maxima found in models assuming simple positive selection.

High epistasis is usually considered a constraining factor on evolution, and improvements in a highly epistatic trait are considered to have lower evolvability. This is because, in any given genetic background, very few mutations will be beneficial, even though many mutations may need to occur to eventually improve the trait. The lack of a smooth landscape makes it harder for evolution to access fitness peaks. In highly rugged landscapes, fitness valleys block access to some genes, and even if ridges exist that allow access, these may be rare or prohibitively long.[45] Moreover, adaptation can move proteins into more precarious or rugged regions of the fitness landscape.[46] These shifting "fitness territories" may act to decelerate evolution and could represent tradeoffs for adaptive traits.

The frustration of adaptive evolution by rugged fitness landscapes was recognized as a potential force for the evolution of evolvability. Michael Conrad in 1972 was the first to propose a mechanism for the evolution of evolvability by noting that a mutation which smoothed the fitness landscape at other loci could facilitate the production of advantageous mutations and hitchhike along with them.[47][48] Rupert Riedl in 1975 proposed that new genes which produced the same phenotypic effects with a single mutation as other loci with reciprocal sign epistasis would be a new means to attain a phenotype otherwise too unlikely to occur by mutation.[49][50]

Rugged, epistatic fitness landscapes also affect the trajectories of evolution. When a mutation has a large number of epistatic effects, each accumulated mutation drastically changes the set of available beneficial mutations. Therefore, the evolutionary trajectory followed depends highly on which early mutations were accepted. Thus, repeats of evolution from the same starting point tend to diverge to different local maxima rather than converge on a single global maximum as they would in a smooth, additive landscape.[51][52]

Evolution of sex

[edit]
Main article: evolution of sexual reproduction

Negative epistasis and sex are thought to be intimately correlated. Experimentally, this idea has been tested in using digital simulations of asexual and sexual populations. Over time, sexual populations move towards more negative epistasis, or the lowering of fitness by two interacting alleles. It is thought that negative epistasis allows individuals carrying the interacting deleterious mutations to be removed from the populations efficiently. This removes those alleles from the population, resulting in an overall more fit population. This hypothesis was proposed by Alexey Kondrashov, and is sometimes known as the deleterious mutation hypothesis[53] and has also been tested using artificial gene networks.[21]

However, the evidence for this hypothesis has not always been straightforward and the model proposed by Kondrashov has been criticized for assuming mutation parameters far from real world observations.[54] In addition, in those tests which used artificial gene networks, negative epistasis is only found in more densely connected networks,[21] whereas empirical evidence indicates that natural gene networks are sparsely connected,[55] and theory shows that selection for robustness will favor more sparsely connected and minimally complex networks.[55]

Methods and model systems

[edit]

Regression analysis

[edit]

Quantitative genetics focuses on genetic variance due to genetic interactions. Any two locus interactions at a particular gene frequency can be decomposed into eight independent genetic effects using a weighted regression. In this regression, the observed two locus genetic effects are treated as dependent variables and the "pure" genetic effects are used as the independent variables. Because the regression is weighted, the partitioning among the variance components will change as a function of gene frequency. By analogy it is possible to expand this system to three or more loci, or to cytonuclear interactions[56]

Double mutant cycles

[edit]

When assaying epistasis within a gene, site-directed mutagenesis can be used to generate the different genes, and their protein products can be assayed (e.g. for stability or catalytic activity). This is sometimes called a double mutant cycle and involves producing and assaying the wild type protein, the two single mutants and the double mutant. Epistasis is measured as the difference between the effects of the mutations together versus the sum of their individual effects.[57] This can be expressed as a free energy of interaction. The same methodology can be used to investigate the interactions between larger sets of mutations but all combinations have to be produced and assayed. For example, there are 120 different combinations of 5 mutations, some or all of which may show epistasis...

Computational prediction

[edit]

Numerous computational methods have been developed for the detection and characterization of epistasis. Many of these rely on machine learning to detect non-additive effects that might be missed by statistical approaches such as linear regression.[58] For example, multifactor dimensionality reduction (MDR) was designed specifically for nonparametric and model-free detection of combinations of genetic variants that are predictive of a phenotype such as disease status in human populations.[59][60] Several of these approaches have been broadly reviewed in the literature.[61] Even more recently, methods that utilize insights from theoretical computer science (the Hadamard transform[62] and compressed sensing[63][64]) or maximum-likelihood inference[65] were shown to distinguish epistatic effects from overall non-linearity in genotype–phenotype map structure,[66] while others used patient survival analysis to identify non-linearity.[67]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Epistasis

View on Grokipedia
from Grokipedia
Epistasis is a phenomenon in genetics in which the phenotypic effect of a gene (or gene mutation) is dependent on the presence or absence of mutations in one or more other genes, such that the effect of one gene masks or modifies the effect of another.[1] The term, meaning "standing upon" in Greek, was coined by William Bateson in 1909 to describe deviations from expected Mendelian ratios in dihybrid crosses.[2] Epistasis plays a fundamental role in understanding gene interactions, complex traits, evolution, and the structure of genetic systems.[3]

Definition and Fundamentals

Core Concept of Gene Interactions

Epistasis refers to the interaction between genes at different loci where the phenotypic effect of one gene, termed the epistatic gene, masks, modifies, or depends on the effect of another gene, known as the hypostatic gene. This occurs when two or more genes contribute to a single phenotype in a non-additive manner, deviating from the independent action expected under Mendelian inheritance. Unlike simple additive effects, epistasis highlights how the expression of alleles at one locus can alter the outcome of alleles at another, leading to modified segregation ratios in offspring.[4][2] Epistasis manifests primarily at the phenotypic level, influencing observable traits through interactions among multiple genetic loci, rather than solely at the genotypic level of DNA sequence. For instance, in mice coat color determination, the agouti locus (A/a) controls the banding pattern of hairs, producing wild-type agouti if dominant (A-), while recessive (aa) yields solid black or brown fur depending on another locus. However, the pigment deposition locus (C/c) acts epistatically; the recessive cc genotype prevents melanin production altogether, resulting in an albino phenotype that masks the effects of the agouti locus regardless of its alleles, and producing a modified 9:3:4 dihybrid ratio in F2 generations.[1][4] Another foundational example comes from William Bateson's 1909 experiments on flower color in sweet peas (Lathyrus odoratus), where crosses between two white-flowered varieties unexpectedly produced purple F1 offspring, followed by an F2 ratio of 9 purple to 7 white instead of the expected 9:3:3:1. This complementary epistasis arises because two genes in the anthocyanin biosynthesis pathway must both have dominant alleles (e.g., C- P- for purple); recessive homozygosity at either locus (cc or pp) blocks pigment production, yielding white flowers and demonstrating how one gene's absence can suppress the other's effect.[1] To clarify prerequisites, epistasis should be distinguished from pleiotropy, in which a single gene influences multiple seemingly unrelated traits, and from polygenic inheritance, where multiple genes contribute additively to variation in a single trait without non-independent interactions. These concepts underscore epistasis as a specific form of gene dependency focused on one phenotype.[5][4]

Additive vs. Non-Additive Effects

In quantitative genetics, additive genetic effects represent the null model where the phenotypic value of an individual is the linear sum of contributions from individual genes or loci, assuming no interactions between them. This model posits that the expected phenotype for a trait influenced by multiple loci is the population mean plus the sum of the average effects of alleles at each locus, such as μ+a1+a2\mu + a_1 + a_2 for two loci, where μ\mu is the overall mean and a1,a2a_1, a_2 are the additive effects of the alleles. For instance, human height, a classic polygenic quantitative trait, is largely explained by such additive effects across numerous loci, where each contributing allele incrementally increases stature without altering the effects of others.[6][7] Additivity serves as the baseline for detecting epistasis, quantified through the epistasis coefficient ε\varepsilon, defined as ε=\varepsilon = observed phenotype −- (sum of single-locus effects), where ε=0\varepsilon = 0 indicates no epistasis and pure additivity. In a two-locus haploid model, this can be expressed as Wxy=αx+αy+εW_{xy} = \alpha_x + \alpha_y + \varepsilon, with WxyW_{xy} as the fitness or phenotypic value of the double mutant, αx\alpha_x and αy\alpha_y as single-mutant effects, and ε\varepsilon capturing any deviation due to interaction; non-zero ε\varepsilon signals non-additivity. This framework, originating from Ronald Fisher's foundational work on Mendelian inheritance, underscores epistasis as a statistical deviation from expected additive contributions.[2][1] Non-additive effects encompass deviations from this additive expectation, primarily arising from dominance (intra-locus interactions) and epistasis (inter-locus interactions), which contribute to genetic variance beyond the linear sum in analysis of variance (ANOVA) frameworks for quantitative traits. In these models, total genetic variance is partitioned into additive (σA2\sigma_A^2), dominance (σD2\sigma_D^2), and epistatic (σI2\sigma_I^2) components, where non-additive terms like σD2\sigma_D^2 and σI2\sigma_I^2 explain phenotypic outcomes not predictable from individual locus effects alone, influencing heritability estimates and breeding responses. For example, in studies of yeast growth rates, additive models often assume multiplicative fitness for double mutants (expected fitness = product of single-mutant fitnesses on a logarithmic scale), but observed deviations—such as positive or negative ε\varepsilon—reveal epistatic non-additivity, where the double-mutant phenotype exceeds or falls short of this product, highlighting interaction strengths.[8][9]

Historical Development

Early Observations in Classical Genetics

The concept of epistasis emerged in the early 20th century through studies in classical genetics that revealed deviations from Mendelian inheritance ratios. In 1909, William Bateson and colleagues coined the term "epistasis" to describe interactions where one gene masks or modifies the phenotypic effect of another, based on observations in chicken comb shapes (e.g., rose and pea combs producing walnut combs when combined) and flower color in sweet peas (Lathyrus odoratus). These findings, reported in crosses showing 9:3:4 or 12:3:1 ratios instead of 9:3:3:1, highlighted non-additive gene interactions and challenged simple dominance models. Earlier work by Bateson, Saunders, and Punnett in 1905–1906 on sweet peas also implied such effects, though the term was formalized later.[1]

Modern Conceptualizations and Key Figures

The one-gene-one-enzyme hypothesis proposed by George Beadle and Edward Tatum in the 1940s posited that each gene directs the synthesis of a single enzyme, emphasizing linear biochemical pathways and initially minimizing the role of gene interactions in phenotypic outcomes. This framework, derived from experiments with Neurospora crassa mutants, supported a modular view of gene function but overlooked non-additive effects like epistasis. However, Seymour Benzer's work in the 1950s using bacteriophage T4 rII mutants advanced the understanding of intragenic interactions, demonstrating through complementation and recombination mapping that mutations within the same gene could interact epistatically, revealing the gene's substructure and challenging the simplistic one-gene model.[10] Key figures in the mid-20th century further integrated epistasis into broader genetic theory. Sewall Wright, from the 1930s to 1960s, developed path analysis as a statistical method to dissect causal relationships among variables, including gene interactions and epistatic effects in quantitative traits and evolutionary landscapes. His approach quantified how epistasis contributes to phenotypic variance beyond additive effects, influencing models of adaptation and genetic architecture.[11] Concurrently, Theodosius Dobzhansky, active from the 1930s to 1970s, incorporated epistasis into population genetics, notably through the Dobzhansky-Muller model, which explains hybrid incompatibilities as negative epistatic interactions between diverged loci in isolated populations.[12] Modern conceptualizations have expanded epistasis into systems biology and genomics. Patrick C. Phillips's 2008 review highlighted network epistasis, framing gene interactions as essential components of genetic pathways and evolutionary dynamics, where pairwise effects propagate through biological networks to influence complex traits. In genome-wide association studies (GWAS), Trudy F. C. Mackay's 2014 analysis of Drosophila melanogaster quantitative trait loci (QTLs) demonstrated pervasive epistasis, with interactions often exceeding main effects and complicating the mapping of additive variants in natural populations. Recent advances in the 2020s leverage CRISPR-Cas9 screens to probe epistasis in disease contexts, particularly synthetic lethality—a form of negative epistasis where combined gene disruptions are deleterious. For instance, 2023 genome-wide CRISPR screens in KRAS/STK11-mutant non-small cell lung cancer models identified recurrent synthetic lethal vulnerabilities, such as dependencies on DNA repair pathways, expanding epistasis studies beyond classical traits to precision oncology.[13] Similarly, pan-cancer analyses using large-scale CRISPR data in 2023 revealed pathway-specific epistatic interactions driving tumor fitness, underscoring their therapeutic potential in targeting context-dependent genetic networks.[14]

Classification Schemes

Magnitude and Sign-Based Types

Epistasis can be classified quantitatively based on its magnitude and sign, focusing on how interactions modify the size and direction of a mutation's effect on fitness, independent of specific biological contexts. These types provide a framework for understanding interaction strength, where magnitude epistasis alters the scale of effects without changing their direction, while sign-based variants involve reversals in effect direction, often leading to complex evolutionary dynamics. Magnitude epistasis refers to situations where the fitness effect of a mutation varies in strength across genetic backgrounds, but retains the same sign (beneficial or deleterious). This can manifest as positive magnitude epistasis, where one mutation amplifies the impact of another—for instance, a second deleterious mutation partially compensates for the first, resulting in higher double-mutant fitness than expected under a multiplicative model— or negative magnitude epistasis, where effects are diminished, such as synergistic harm exceeding multiplicativity. In studies of RNA viruses like tobacco etch virus, both magnitude and sign epistasis were observed among deleterious mutations, with double mutants showing deviations in effect size that preserved the overall negative direction in magnitude cases. These interactions highlight reinforcement or suppression without flipping outcomes, contrasting with additive effects where no such scaling occurs.[15] Sign epistasis occurs when the directional effect of a mutation reverses depending on the genetic background, such that a mutation beneficial in isolation becomes deleterious in combination, or vice versa. This phenomenon is critical for generating rugged fitness landscapes, as it constrains accessible evolutionary paths by making certain mutations inaccessible in specific contexts. For example, in RNA viruses like tobacco etch virus, certain deleterious mutations became beneficial in specific double-mutant combinations, demonstrating sign reversal. Mathematically, in a continuous fitness landscape where fitness $ w $ depends on mutations $ m_1 $ and $ m_2 $, sign epistasis is evident if the partial derivative satisfies $ \frac{\partial w}{\partial m_1} > 0 $ without $ m_2 $, but $ \frac{\partial w}{\partial m_1} < 0 $ with $ m_2 $ present, indicating a background-dependent sign flip.[16] Reciprocal sign epistasis represents a more extreme form, where the sign of each mutation's fitness effect is contingent on the other mutation's presence, often resulting in both single mutants being less fit than the wild type while the double mutant exceeds it. This mutual dependency creates multiple local fitness peaks, as the pathway to the higher peak requires simultaneous changes that are individually unfavorable. Observed in viral evolution experiments, reciprocal sign epistasis was identified in over 90% of sign epistasis cases among deleterious mutations, underscoring its role in landscape ruggedness. Such configurations are necessary for multi-peaked topologies, limiting adaptive trajectories to specific routes.[17][18][19]

Context in Haploid and Diploid Systems

In haploid organisms, the absence of a second allele set enables a direct correspondence between genotype and phenotype, facilitating the unambiguous detection of epistatic interactions without the confounding effects of dominance or masking. All mutations are expressed, allowing researchers to map genetic interactions comprehensively and identify forms such as sign epistasis, where the effect of one mutation depends on the presence of another in altering fitness. For instance, in the yeast Saccharomyces cerevisiae, a systematic analysis of more than 23 million double-mutant combinations produced a global genetic interaction network encompassing over 6 million pairwise genetic interactions, revealing that sign epistasis is prevalent in essential gene pathways and simplifies the study of non-additive effects compared to diploid systems.[20] In diploid organisms, epistasis is often modulated by heterozygosity, which can conceal recessive alleles and lead to masking interactions that alter phenotypic outcomes in complex ways. Recessive epistasis occurs when a homozygous recessive genotype at one locus prevents the expression of alleles at another locus, regardless of their dominance. A well-documented human example is the Bombay phenotype, where individuals homozygous for a recessive mutation in the FUT1 gene (encoding the H antigen precursor) fail to produce the H substance required for ABO blood group antigens, resulting in an apparent type O blood phenotype irrespective of their ABO genotype; this interaction exemplifies how one gene can epistatically suppress another in diploids.[21] Polyploid systems extend these dynamics, with multiple genome copies introducing dosage effects that can intensify the magnitude of epistatic interactions through imbalances in gene product levels. In crops like hexaploid wheat (Triticum aestivum), elevated ploidy amplifies quantitative trait variation via homoeologous gene interactions, where dosage sensitivity disrupts expression balance and enhances non-additive effects on traits such as yield components. This is supported by the gene balance hypothesis, which posits that polyploidy alters stoichiometric relationships among gene products, thereby magnifying epistatic contributions to phenotypic stability and evolvability.[22][23] Ploidy levels can influence the strength and detection of epistatic interactions across different life cycle stages, with haploid phases potentially revealing stronger effects due to lack of dominance masking compared to diploid phases.

Molecular and Genetic Mechanisms

Intergenic Interactions

Intergenic interactions in epistasis arise primarily from the functional dependencies between proteins or pathways encoded by different genes, leading to non-additive phenotypic effects. One key biochemical mechanism is suppression, where a mutation in one gene compensates for the deleterious effect of a mutation in another gene, often through redundant pathways that maintain overall pathway flux or activity. For instance, in yeast, intergenic suppressors can restore wild-type activity levels within a shared biochemical pathway by providing alternative routes for metabolite processing, effectively buffering the primary mutation's impact.[24] Enhancement represents another form of intergenic interaction, where mutations in sequentially acting enzymes or components amplify each other's effects, particularly in signaling cascades. In such cascades, the phenotypic output depends on the hierarchical tuning of parameters like dissociation constants between upstream and downstream genes; a mutation in an upstream gene can alter the optimal function of a downstream gene, resulting in exaggerated fitness costs or benefits. This is exemplified in Escherichia coli transcriptional signaling networks involving repressors, where sign epistasis—masking of a mutation's effect based on genetic background—occurs more frequently downstream, altering signal transduction efficiency.[25] Network-level epistasis emerges from interactions within protein-protein or gene regulatory networks, where the combined disruption of genes in parallel pathways leads to severe phenotypes not predicted by individual effects. A prominent example is synthetic lethality in yeast (Saccharomyces cerevisiae), where genes in mutually compensatory parallel pathways, such as those in phosphatidylcholine synthesis (e.g., CHO2 in methylation and PCT1 in the Kennedy pathway), show viable single mutants but inviable double mutants under nutrient-rich conditions due to the failure of redundancy. Similarly, in metabolic networks, synthetic interactions between SAM1 and SAM2 (S-adenosylmethionine synthetases) are condition-specific, rescued by exogenous supplementation, highlighting how parallel routes buffer perturbations until both are compromised.[26] In E. coli, intergenic masking is illustrated by sign epistasis in a synthetic transcriptional cascade using the repressor lacI downstream of tetR, driving YFP expression. Mutations in lacI can mask or enhance effects depending on the tetR background, as the repressor's parameters influence overall cascade output; for example, altered lacI variants change the sign of fitness effects in the cascade.[25] Quantitative modeling of these intergenic effects often employs flux balance analysis (FBA) in metabolic networks to capture epistasis as deviations in flux from additivity. In FBA, the epistasis measure ε is defined as ε = Δflux_{double} - (Δflux_1 + Δflux_2), where Δflux represents the change in metabolic flux (e.g., biomass production rate) for double and single knockouts relative to wild-type; positive ε indicates suppression via redundancy, while negative ε reflects enhancement or synthetic lethality. This approach reveals prevalent positive epistasis (>97% of pairs in E. coli, >95% in yeast) particularly between non-overlapping reactions, underscoring the role of biochemical connectivity in intergenic interactions.[27]

Intragenic and Allelic Effects

Intragenic epistasis occurs when multiple mutations within the same gene interact to produce non-additive effects on phenotype, often through mechanisms like compensatory changes that mitigate the deleterious impact of an initial mutation. A meta-analysis of protein evolution studies reveals that approximately 83% of compensatory mutations—where a secondary mutation restores function or stability lost by the primary one—are intragenic, underscoring their prevalence in maintaining protein integrity. For instance, in enzymes like TEM-1 β-lactamase, compensatory mutations frequently cluster near deleterious sites within structurally critical regions to counteract destabilizing effects and enable evolutionary adaptation. These interactions highlight how intragenic epistasis can facilitate functional resilience without requiring intergenic changes.[28][29] Allelic series represent another facet of intragenic effects, where multiple alleles at a single locus form dominance hierarchies that mask or modify each other's expression in heterozygotes, effectively acting as intragenic epistasis. In sickle cell anemia, the hemoglobin β-globin gene (HBB) exhibits such a series: the wild-type HbA allele dominates over the sickle-cell HbS allele, preventing full sickling in HbA/HbS heterozygotes (sickle cell trait), though the combination yields an intermediate phenotype with partial resistance to malaria due to non-additive interactions at the molecular level. This dominance hierarchy illustrates how one allele can epistatically suppress the pathological effects of another within the same gene, influencing clinical outcomes.[30] Heterozygotic epistasis is evident in compound heterozygotes, where distinct mutations in the same gene produce phenotypes that deviate from expected additivity, often resulting in variable disease severity. In cystic fibrosis, caused by mutations in the CFTR gene, compound heterozygotes carrying mutations of different classes (e.g., class II affecting protein folding and class I causing premature termination) display a spectrum of lung and pancreatic involvement influenced by the combined effects on CFTR function. Such cases emphasize the role of intragenic allelic interactions in modulating monogenic disease expressivity.[31] Recent advances have extended intragenic epistasis to non-coding regions, particularly cis-regulatory elements like enhancers, where variant interactions influence gene expression without altering coding sequences. These findings update understandings of intragenic dynamics, revealing how non-coding epistasis contributes to polygenic traits in complex human genetics. For example, as of 2024, methods like Next-Gen GWAS have enabled detection of epistatic interactions among non-coding variants, helping retrieve missing heritability in traits like height.[32]

Evolutionary and Biological Impacts

Fitness Landscapes and Evolvability

Fitness landscapes provide a conceptual framework for understanding evolution as a process of navigating genotypic space toward higher fitness, where epistasis introduces complexity by creating rugged terrains with multiple peaks and valleys. Sewall Wright introduced this metaphor in 1932, visualizing genotypes as points on a multidimensional surface where fitness determines elevation, and epistatic interactions between loci generate "hilly" landscapes rather than smooth gradients.[33] In such landscapes, sign epistasis—where the fitness effect of a mutation depends on the genetic background—can produce multiple local optima, trapping populations on suboptimal peaks and limiting access to global maxima.[34] Epistasis profoundly influences evolvability, defined as the capacity of a population to generate adaptive genetic variation. Positive magnitude epistasis, where combined mutations have less severe fitness effects than expected additively, promotes canalization by buffering deleterious mutations, thereby maintaining phenotypic stability and facilitating the accumulation of cryptic variation for future adaptation.[35] Conversely, reciprocal sign epistasis, involving mutations that are individually deleterious but jointly beneficial, creates fitness valleys that hinder evolutionary trajectories, as intermediate genotypes suffer reduced viability and are unlikely to fix under selection.[36] The NK model, developed by Stuart Kauffman in 1993, mathematically represents these dynamics in tunable fitness landscapes. In this framework, a genotype consists of N binary loci, each contributing to overall fitness W, with the epistasis parameter K (0 ≤ K ≤ N-1) quantifying interdependencies: the fitness contribution ε of each locus i is a random function f_i of its own state and K randomly chosen other loci, such that W = (1/N) Σ ε_i. As K increases, landscape ruggedness grows, with more local peaks emerging due to heightened epistatic interactions, which can constrain evolvability by increasing the number of inaccessible optima.[37] An illustrative example occurs in the evolution of HIV drug resistance, where sign epistasis traps viral populations on suboptimal paths. In HIV-1 subtype B protease, primary resistance mutations like I84V confer initial fitness costs that are exacerbated by sign epistasis with secondary mutations, creating rugged landscapes where direct adaptive routes are blocked, entrenching resistance only through permissive genetic backgrounds.[38]

Influences on Reproduction and Adaptation

Epistasis plays a pivotal role in the evolution of sexual reproduction by influencing the efficacy of masking deleterious mutations in diploid organisms. In diploids, negative epistasis reduces the protective effect of masking, where wild-type alleles typically conceal the fitness costs of recessive deleterious mutations; this increases the mutation load in asexual lineages, favoring recombination to disassemble harmful gene combinations and purge mutations more effectively.[39] Such dynamics help avert Muller's ratchet, the irreversible accumulation of deleterious mutations in asexual populations, thereby providing a selective advantage to sex and recombination in maintaining genetic health.[40] In the context of adaptation and speciation, epistatic interactions underlie Dobzhansky-Muller incompatibilities, where alleles that evolve independently in isolated populations interact negatively in hybrids, leading to reduced fitness such as sterility. This model explains hybrid sterility as arising from mismatched genetic backgrounds rather than direct selection against hybrids, with negative epistasis amplifying the dysfunction between diverged loci. A well-documented example occurs in Drosophila species, such as D. pseudoobscura and D. persimilis, where multiple epistatic factors on the X chromosome contribute to male hybrid sterility through homozygous incompatibilities in F2 generations.[41][42] Recent genomic studies have highlighted cytonuclear epistasis—interactions between nuclear and cytoplasmic genomes—in shaping adaptation in plant hybrids, particularly under varying climatic conditions. In Populus hybrid zones, cytonuclear mismatches disrupt co-adapted gene complexes, influencing traits like growth and survival across environmental gradients, with epistatic effects modulated by local climate variables such as temperature and precipitation. These findings underscore how such incompatibilities can hinder or facilitate hybrid adaptation to climate change, revealing a gap in earlier models by integrating organelle-nuclear dynamics.[43] Negative epistasis in pathogen genomes accelerates arms-race coevolution with hosts by imposing accelerating fitness costs on multiple virulence mutations, thereby sustaining rapid cycles of adaptation and counter-adaptation. In multilocus gene-for-gene systems, this form of epistasis expands the parameter space for coevolutionary fluctuations, maintaining higher average virulence in parasites and preventing stable equilibria, which intensifies the selective pressure on both parties. For instance, models of bacterial-phage interactions demonstrate that negative epistasis buffers initial mutation costs while driving escalated trait evolution, contrasting with linear interactions that lead to slower dynamics.[44]

Detection and Modeling Approaches

Statistical and Regression Methods

Statistical methods for detecting and quantifying epistasis rely on regression and variance partitioning techniques to model interactions between loci while controlling for main effects. Multiple linear regression serves as a foundational approach for analyzing continuous phenotypes in two-locus models, where the phenotype $ Y $ is expressed as $ Y = \beta_0 + \beta_1 G_1 + \beta_2 G_2 + \beta_{12} G_1 G_2 + \epsilon $, with $ G_1 $ and $ G_2 $ representing genotypes at each locus coded as 0, 1, or 2, and the interaction term $ \beta_{12} G_1 G_2 $ testing for epistasis through its significance via F-tests or t-tests.[45] This model extends additive effects by incorporating the product term to capture non-additive deviations, enabling estimation of epistatic contributions in quantitative trait loci (QTL) mapping studies.[46] Analysis of variance (ANOVA) provides a complementary framework for partitioning total phenotypic variance into additive ($ V_A ),dominance(), dominance ( V_D ),andepistatic(), and epistatic ( V_I $) components, particularly in breeding designs like diallel crosses or recombinant inbred lines. Ronald Fisher introduced this decomposition in 1918, formalizing genetic variance as $ V_P = V_A + V_D + V_I + V_E $, where $ V_E $ is environmental variance, and epistatic terms are derived from higher-order interactions in multi-locus ANOVA models. In practice, two-way ANOVA for digenic epistasis assesses the significance of the locus-by-locus interaction mean square against the error term, allowing estimation of $ V_I $ as a proportion of total genetic variance in populations.[47] For categorical traits, such as disease presence or absence, log-linear models analyze contingency tables to detect epistatic deviations from independence between loci. These models parameterize the log-expected cell frequencies in a multi-way table as $ \log \mu_{ijk\dots} = \lambda + \sum \lambda_i^A + \sum \lambda_j^B + \sum \lambda_{ij}^{AB} + \higher terms $, where the interaction parameters $ \lambda_{ij}^{AB} $ quantify epistasis through likelihood ratio tests comparing hierarchical models.[48] This approach is particularly useful for case-control studies, as it handles sparse data via Poisson regression equivalents and avoids logistic regression biases in multi-locus settings.[49] Despite their utility, these statistical methods face significant limitations in high-dimensional genomic data, where the curse of dimensionality arises from the combinatorial explosion of locus pairs (e.g., millions for 20,000 SNPs), leading to sparse data, multiple testing burdens, and reduced power for detecting multi-locus epistasis.[50] Recent advances preview machine learning extensions to mitigate these issues, though traditional regression and ANOVA remain essential for interpretable variance partitioning in lower-dimensional contexts.[51]

Experimental and Computational Techniques

Experimental techniques for probing epistasis often involve constructing and analyzing pairwise or higher-order mutants to quantify non-additive genetic interactions. Double-mutant cycles (DMCs) represent a foundational biochemical approach, where the wild-type protein, two single mutants, and the corresponding double mutant are generated to measure the coupling energy (ε) between residues, defined as ε = ΔΔG_binding = (G_double - G_wt) - (G_single1 - G_wt) - (G_single2 - G_wt), revealing direct or long-range interactions underlying structural epistasis.[52] This method, originally developed for protein folding and binding studies, has been extended to detect epistatic effects in protein stability and function, with applications in enzyme engineering and allostery.[53] For instance, DMCs have quantified epistasis in stabilizing mutations across protein domains, showing how coupled dynamics propagate effects over distances exceeding 20 Å.[54] High-throughput experimental systems leverage genetic libraries to map epistatic networks at scale. In yeast (Saccharomyces cerevisiae), systematic deletion libraries combined with synthetic genetic array (SGA) technology enable the construction of double mutants across the genome, identifying negative (synthetic lethal) and positive epistatic interactions that reveal functional redundancies and pathways. A 2019 study using these libraries in multiple yeast strains uncovered complex epistatic landscapes influencing drug responses, such as statin sensitivity, where 18.5% of gene deletion phenotypes varied by genetic background, highlighting context-dependent interactions.[55] In mammalian cells, CRISPR-Cas9-based screens have advanced epistasis detection, particularly in cancer models. Combinatorial CRISPR libraries targeting tumor suppressor genes in lung adenocarcinoma cell lines and in vivo models identified widespread epistatic networks, with 45 pairwise interactions modulating tumor growth and therapeutic resistance, emphasizing non-additive effects in oncogenesis.[56] These 2025 screens in human cell lines demonstrated that epistasis between paralogs, like synthetic lethals in 27 cancer cell lines, can guide precision oncology by pinpointing context-specific vulnerabilities.[57] Model organisms like Caenorhabditis elegans facilitate high-throughput epistasis studies due to their tractable genetics and short generation times. Deletion mutant libraries and CRISPR-Cas9 editing allow systematic phenotyping of double mutants for developmental and fitness traits, with quantitative imaging pipelines enabling analysis of thousands of interactions.[58] Recent applications include high-throughput epistasis studies using quantitative imaging pipelines to analyze double mutants for developmental and fitness traits. Mitonuclear epistasis has been shown to affect lifespan in C. elegans.[59] These systems complement yeast and mammalian approaches by providing whole-organism insights into epistasis in multicellular contexts. Computational techniques predict epistasis by simulating structural and sequence-based interactions, often integrating experimental data for validation. Molecular dynamics (MD) simulations model atomic-level dynamics to uncover structural bases of epistasis, such as in SARS-CoV-2 spike protein variants where MD revealed mutation-induced affinity changes and allosteric effects driving immune evasion.[60] In dihydrofolate reductase, MD trajectories identified conformational shifts responsible for higher-order epistasis in drug resistance, with simulations spanning microseconds to quantify energetic couplings not captured by static structures.[61] Machine learning (ML) methods, enhanced by AlphaFold2 predictions, forecast epistatic effects from sequence data. A 2024 deep learning model incorporating protein dynamics outperformed prior tools in predicting double-mutant fitness effects, achieving up to 20% higher accuracy on unseen variants by learning non-additive interactions in enzyme landscapes.[62] AlphaFold-derived interaction maps have mapped epistatic drivers in viral proteins, using predicted structures to simulate binding energetics and identify permissive mutation paths in evolving pathogens.[63] These in silico approaches scale to genome-wide predictions, guiding targeted experiments in diverse systems.

References

  1. Epistasis and Its Effects on Phenotype | Learn Science at Scitable
  2. Epistasis: what it means, what it doesn't mean, and statistical ...
  3. Epistasis—the essential role of gene interactions in the structure and ...
  4. Pleiotropy: One Gene Can Affect Multiple Traits - Nature
  5. From Galton to GWAS: quantitative genetics of human height
  6. Chapter 5: Gene Effects – Quantitative Genetics for Plant Breeding
  7. [PDF] Epistasis and Plant Breeding - James B. Holland - USDA ARS
  8. The strength of genetic interactions scales weakly with mutational ...
  9. Suppressor Mutants: History and Today's Applications - PMC
  10. MULTIPLE FITNESS PEAKS AND EPISTASIS - Annual Reviews
  11. Evolutionary Genetics of Hybrid Incompatibility - Nature
  12. Pathway-driven analysis of synthetic lethal interactions in cancer ...
  13. Magnitude and sign epistasis among deleterious mutations in a ...
  14. The causes of epistasis | Proceedings of the Royal Society B
  15. Epistasis and evolution: recent advances and an outlook for prediction
  16. SIGN EPISTASIS AND GENETIC COSTRAINT ON EVOLUTIONARY ...
  17. Reciprocal sign epistasis is a necessary condition for multi-peaked ...
  18. Reciprocal sign epistasis is a necessary condition for multi-peaked ...
  19. A global genetic interaction network maps a wiring ... - PubMed - NIH
  20. Epistasis: Multiple sclerosis and the major histocompatibility complex
  21. Gene balance hypothesis: Connecting issues of dosage sensitivity ...
  22. Genomic variants affecting homoeologous gene expression dosage ...
  23. Rapid creation of Arabidopsis doubled haploid lines for quantitative ...
  24. Genetic suppression: Extending our knowledge from lab ... - NIH
  25. Sign epistasis caused by hierarchy within signalling cascades - PMC
  26. Plasticity of genetic interactions in metabolic networks of yeast - PNAS
  27. Prevalent positive epistasis in E. coli and S. cerevisiae metabolic ...
  28. Systematic Survey of an Intragenic Epistatic Landscape
  29. Compensatory mutations are repeatable and clustered within proteins
  30. https://www.nature.com/scitable/topicpage/genetic-dominance-genotype-phenotype-relationships-489
  31. Cystic Fibrosis Mutations for p.F508del Compound Heterozygotes ...
  32. Concurrent outcomes from multiple approaches of epistasis analysis ...
  33. [PDF] The Heuristic Role of Sewall Wright's 1932 Adaptive Landscape ...
  34. Visualizing fitness landscapes - PMC - NIH
  35. THE CAUSES OF EPISTASIS IN GENETIC NETWORKS
  36. Reciprocal Sign Epistasis between Frequently Experimentally ...
  37. Measuring epistasis in fitness landscapes: The correlation of fitness ...
  38. Epistasis and entrenchment of drug resistance in HIV-1 subtype B
  39. Hidden Epistastic Interactions Can Favour the Evolution of Sex and ...
  40. Muller's ratchet, epistasis and mutation effects. - Oxford Academic
  41. Dominance, epistasis and the genetics of postzygotic isolation - PMC
  42. Epistasis among Drosophila persimilis factors conferring hybrid ...
  43. Epistatic Interactions Alter Dynamics of Multilocus Gene-for-Gene ...
  44. A complete classification of epistatic two-locus models - PMC
  45. The use of weighted multiple linear regression to estimate QTL-by ...
  46. [PDF] Mapping QTLs with epistatic effects and QTL×environment ...
  47. Log-linear model-based multifactor dimensionality reduction method ...
  48. BOOST: A Fast Approach to Detecting Gene-Gene Interactions ... - NIH
  49. A survey about methods dedicated to epistasis detection - PMC
  50. Gene-gene interaction: the curse of dimensionality - PubMed Central
  51. Double-mutant cycles: a powerful tool for analyzing protein structure ...
  52. Double-mutant cycles: new directions and applications - PubMed
  53. Coupled molecular dynamics mediate long- and short-range ... - PNAS
  54. Combinatorial In Vivo Genome Editing Identifies Widespread ...
  55. A compendium of synthetic lethal gene pairs defined by extensive ...
  56. A strategy to apply quantitative epistasis analysis on developmental ...
  57. Structural and molecular basis of the epistasis effect in enhanced ...
  58. High-Order Epistasis in Catalytic Power of Dihydrofolate Reductase ...
  59. A protein dynamics–based deep learning model enhances ... - PNAS
  60. https://pubmed.ncbi.nlm.nih.gov/39339934/
User Avatar
No comments yet.